Show Summary Details
Page of

Hepatitis C 

Hepatitis C

Chapter:
Hepatitis C
Author(s):

Paul Klenerman

, K.J.M. Jeffery

, and J. Collier

DOI:
10.1093/med/9780199204854.003.070522_update_002

Update:

Genetic predictors of acute viral clearance and response to treatment.

Further information on directly acting antiviral agents (DAAs) and new drugs in development.

Updated on 31 May 2012. The previous version of this content can be found here.
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2015. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy).

date: 21 July 2017

Hepatitis C virus (HCV) is an RNA virus that has evolved into multiple genotypes (1–6) and subtypes. Humans are the only known natural host. HCV replication is highly error-prone, hence within any one person the virus exists as a swarm of closely related variants, known as ‘quasispecies’....

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.